Further information on the content of these sessions will be made available once details have been confirmed.
Addressing contemporary challenges in the management of spasticity, this session will cover topics including the real-world impact of public clinic capacity constraints and how this can be balanced against the value of early intervention for spasticity patients. The discussion will also explore considerations when treating special patient populations.
Effectiveness of adult spasticity (AS) management with botulinumtoxinA (BoNT-A) is closely linked to patient‑informed goal setting, shared decision‑making, and personalised, multidisciplinary team‑delivered treatment plans and care pathways.1
Join your colleagues, including rehabilitation physicians, nurses and allied health professionals, for this workshop-style session with our multidisciplinary rehabilitation medicine facilitators. After reviewing the latest evidence on BoNT-A safety and symptom control in upper limb spasticity, groups will participate in interactive case study-based activities that address implementation of patient-centred goals informed by lived experience and practical considerations for treatment decision making. The session will also consider multidisciplinary team approaches for best-practice clinical management of AS.
1. Verduzco‑Gutierrez M, et al. AAPM&R consensus guidance on spasticity assessment and management. PM&R. 2024;16(8):864-887.
DYS-AU-002096. Date of approval: June 2026.
Dr Stephen de Graaff is a Past President of the Australasian Faculty of Rehabilitation Medicine (Royal Australasian College of Physicians). He is Director of Pain Services and Senior Rehabilitation Physician at Epworth Healthcare. He is a Fellow of the AFRM (RACP) and a Founding Member of the Rehabilitation Society of Australia and New Zealand (RMSANZ).
Dr de Graaff is the Chair of the RMSANZ Spasticity Management Special Interest Group. His areas of research interest include Stroke Rehabilitation, Spasticity Management, Pain Management, Post-Polio Sequelae & Continuing Professional Development. He has presented at both national and international meetings and co-authored a number of papers in these domains and currently is involved in a number of research projects particularly in spasticity management and pain management.
Dr Hannah Barden is an Occupational Therapist based in Sydney where she works as the senior clinical researcher at Westmead Hospital’s Brain Injury Rehabilitation Service. She was awarded her PhD in 2015 for research into novel measurement techniques for adults with upper limb spasticity undergoing spasticity management. Hannah holds an Honorary appointment, Clinical Senior Lecturer at The University of Sydney, Discipline of Occupational Therapy, Sydney School of Health Sciences, Faculty of Medicine and Health. Her research and interests include clinical assessment and management of motor and cognitive impairments after neurological injury for improving patient outcomes.